2022-12-012023-11-302023-11-30false12300398SKIN SUBLIME LIMITED2024-07-1886220iso4217:GBPxbrli:pure123003982022-12-01123003982023-11-30123003982022-12-012023-11-30123003982021-12-01123003982022-11-30123003982021-12-012022-11-3012300398bus:SmallEntities2022-12-012023-11-3012300398bus:AuditExempt-NoAccountantsReport2022-12-012023-11-3012300398bus:FullAccounts2022-12-012023-11-3012300398bus:PrivateLimitedCompanyLtd2022-12-012023-11-3012300398core:WithinOneYear2023-11-3012300398core:AfterOneYear2023-11-3012300398core:WithinOneYear2022-11-3012300398core:AfterOneYear2022-11-3012300398core:ShareCapital2023-11-3012300398core:SharePremium2023-11-3012300398core:RevaluationReserve2023-11-3012300398core:OtherReservesSubtotal2023-11-3012300398core:RetainedEarningsAccumulatedLosses2023-11-3012300398core:ShareCapital2022-11-3012300398core:SharePremium2022-11-3012300398core:RevaluationReserve2022-11-3012300398core:OtherReservesSubtotal2022-11-3012300398core:RetainedEarningsAccumulatedLosses2022-11-3012300398core:LandBuildings2023-11-3012300398core:PlantMachinery2023-11-3012300398core:Vehicles2023-11-3012300398core:FurnitureFittings2023-11-3012300398core:OfficeEquipment2023-11-3012300398core:NetGoodwill2023-11-3012300398core:IntangibleAssetsOtherThanGoodwill2023-11-3012300398core:ListedExchangeTraded2023-11-3012300398core:UnlistedNon-exchangeTraded2023-11-3012300398core:LandBuildings2022-11-3012300398core:PlantMachinery2022-11-3012300398core:Vehicles2022-11-3012300398core:FurnitureFittings2022-11-3012300398core:OfficeEquipment2022-11-3012300398core:NetGoodwill2022-11-3012300398core:IntangibleAssetsOtherThanGoodwill2022-11-3012300398core:ListedExchangeTraded2022-11-3012300398core:UnlistedNon-exchangeTraded2022-11-3012300398core:LandBuildings2022-12-012023-11-3012300398core:PlantMachinery2022-12-012023-11-3012300398core:Vehicles2022-12-012023-11-3012300398core:FurnitureFittings2022-12-012023-11-3012300398core:OfficeEquipment2022-12-012023-11-3012300398core:NetGoodwill2022-12-012023-11-3012300398core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3012300398core:ListedExchangeTraded2022-12-012023-11-3012300398core:UnlistedNon-exchangeTraded2022-12-012023-11-3012300398core:MoreThanFiveYears2022-12-012023-11-3012300398core:Non-currentFinancialInstruments2023-11-3012300398core:Non-currentFinancialInstruments2022-11-3012300398dpl:CostSales2022-12-012023-11-3012300398dpl:DistributionCosts2022-12-012023-11-3012300398core:LandBuildings2022-12-012023-11-3012300398core:PlantMachinery2022-12-012023-11-3012300398core:Vehicles2022-12-012023-11-3012300398core:FurnitureFittings2022-12-012023-11-3012300398core:OfficeEquipment2022-12-012023-11-3012300398dpl:AdministrativeExpenses2022-12-012023-11-3012300398core:NetGoodwill2022-12-012023-11-3012300398core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3012300398dpl:GroupUndertakings2022-12-012023-11-3012300398dpl:ParticipatingInterests2022-12-012023-11-3012300398dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3012300398core:ListedExchangeTraded2022-12-012023-11-3012300398dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3012300398core:UnlistedNon-exchangeTraded2022-12-012023-11-3012300398dpl:CostSales2021-12-012022-11-3012300398dpl:DistributionCosts2021-12-012022-11-3012300398core:LandBuildings2021-12-012022-11-3012300398core:PlantMachinery2021-12-012022-11-3012300398core:Vehicles2021-12-012022-11-3012300398core:FurnitureFittings2021-12-012022-11-3012300398core:OfficeEquipment2021-12-012022-11-3012300398dpl:AdministrativeExpenses2021-12-012022-11-3012300398core:NetGoodwill2021-12-012022-11-3012300398core:IntangibleAssetsOtherThanGoodwill2021-12-012022-11-3012300398dpl:GroupUndertakings2021-12-012022-11-3012300398dpl:ParticipatingInterests2021-12-012022-11-3012300398dpl:GroupUndertakingscore:ListedExchangeTraded2021-12-012022-11-3012300398core:ListedExchangeTraded2021-12-012022-11-3012300398dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-12-012022-11-3012300398core:UnlistedNon-exchangeTraded2021-12-012022-11-3012300398core:NetGoodwill2023-11-3012300398core:IntangibleAssetsOtherThanGoodwill2023-11-3012300398core:LandBuildings2023-11-3012300398core:PlantMachinery2023-11-3012300398core:Vehicles2023-11-3012300398core:FurnitureFittings2023-11-3012300398core:OfficeEquipment2023-11-3012300398core:AfterOneYear2023-11-3012300398core:WithinOneYear2023-11-3012300398core:ListedExchangeTraded2023-11-3012300398core:UnlistedNon-exchangeTraded2023-11-3012300398core:ShareCapital2023-11-3012300398core:SharePremium2023-11-3012300398core:RevaluationReserve2023-11-3012300398core:OtherReservesSubtotal2023-11-3012300398core:RetainedEarningsAccumulatedLosses2023-11-3012300398core:NetGoodwill2022-11-3012300398core:IntangibleAssetsOtherThanGoodwill2022-11-3012300398core:LandBuildings2022-11-3012300398core:PlantMachinery2022-11-3012300398core:Vehicles2022-11-3012300398core:FurnitureFittings2022-11-3012300398core:OfficeEquipment2022-11-3012300398core:AfterOneYear2022-11-3012300398core:WithinOneYear2022-11-3012300398core:ListedExchangeTraded2022-11-3012300398core:UnlistedNon-exchangeTraded2022-11-3012300398core:ShareCapital2022-11-3012300398core:SharePremium2022-11-3012300398core:RevaluationReserve2022-11-3012300398core:OtherReservesSubtotal2022-11-3012300398core:RetainedEarningsAccumulatedLosses2022-11-3012300398core:NetGoodwill2021-12-0112300398core:IntangibleAssetsOtherThanGoodwill2021-12-0112300398core:LandBuildings2021-12-0112300398core:PlantMachinery2021-12-0112300398core:Vehicles2021-12-0112300398core:FurnitureFittings2021-12-0112300398core:OfficeEquipment2021-12-0112300398core:AfterOneYear2021-12-0112300398core:WithinOneYear2021-12-0112300398core:ListedExchangeTraded2021-12-0112300398core:UnlistedNon-exchangeTraded2021-12-0112300398core:ShareCapital2021-12-0112300398core:SharePremium2021-12-0112300398core:RevaluationReserve2021-12-0112300398core:OtherReservesSubtotal2021-12-0112300398core:RetainedEarningsAccumulatedLosses2021-12-0112300398core:AfterOneYear2022-12-012023-11-3012300398core:WithinOneYear2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:CostValuation2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3012300398core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3012300398core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3012300398core:Non-currentFinancialInstrumentscore:CostValuation2022-11-3012300398core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-3012300398core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-3012300398bus:Director12022-12-012023-11-30123003981bus:Director12022-12-01123003981bus:Director12022-12-012023-11-30123003981bus:Director12023-11-30123003982022-12-01123003982022-12-012023-11-30123003982023-11-30

SKIN SUBLIME LIMITED

Registered Number
12300398
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2023

SKIN SUBLIME LIMITED
Company Information
for the year from 1 December 2022 to 30 November 2023

Director

Dr Emma McMullen

Registered Address

34 Lapwing Lane Lapwing Lane
Manchester
M20 2WR

Registered Number

12300398 (England and Wales)
SKIN SUBLIME LIMITED
Balance Sheet as at
30 November 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets390380
90380
Current assets
Debtors416,8196,251
16,8196,251
Creditors amounts falling due within one year5(16,745)(7,573)
Net current assets (liabilities)74(1,322)
Total assets less current liabilities164(942)
Net assets164(942)
Capital and reserves
Called up share capital33
Profit and loss account161(945)
Shareholders' funds164(942)
The financial statements were approved and authorised for issue by the Director on 18 July 2024, and are signed on its behalf by:
Dr Emma McMullen
Director
Registered Company No. 12300398
SKIN SUBLIME LIMITED
Notes to the Financial Statements
for the year ended 30 November 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20232022
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 December 221,3131,313
At 30 November 231,3131,313
Depreciation and impairment
At 01 December 22933933
Charge for year290290
At 30 November 231,2231,223
Net book value
At 30 November 239090
At 30 November 22380380
4.Debtors: amounts due within one year

2023

2022

££
Other debtors16,8196,251
Total16,8196,251
Short term trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2023

2022

££
Taxation and social security16,7457,573
Total16,7457,573
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
6.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Dr Emma McMullen6,25116,8186,25116,818
The Director repaid this loan within 9 months of the year end
6,25116,8186,25116,818